fda warning bpc-157 peptide products unapproved FDA Compliance for Peptide Therapy and BPC-157 – Holt Law bpc 157 fda status fda

Things have got A LOT better since then

The answer is a resounding yes

Abstract Significance: The antiulcer peptide, stable gastric pentadecapeptide BPC 157 (previously employed in ulcerative colitis and multiple sclerosis trials, no reported toxicity (LD1 not achieved)), is reviewed, focusing on the particular skin wound therapy, incisional/excisional wound, deep burns, diabetic ulcers, and alkali burns, which may be generalized to the other tissues healing

So, if for example you experience worse fatigue after B12 injections, it might be a brief phase where your body is still using the unhealthy red blood cells